Previous close | 2.3500 |
Open | 2.3500 |
Bid | 0.0000 |
Ask | 4.3000 |
Strike | 437.50 |
Expiry date | 2024-06-28 |
Day's range | 2.3500 - 2.3500 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Investors are in a gambling mood for S&P 500 stocks again. And it's paying off. If you invested $10,000 in January in the top-performing stock in the S&P 500 at the time and reinvested that in each month's top performer, including Caesars Entertainment in June, you'd have $49,604 now, says an Investor's Business Daily analysis of data from S&P Global Market Intelligence and MarketSurge.
Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.
(Bloomberg) -- S&P Global Inc. named Martina Cheung, the president of its credit ratings division, as its next chief executive officer. Most Read from BloombergBiden’s Disastrous Debate Accelerates Doubts Over CandidacyBiden Struggles as He Spars With Trump on Economy: Debate TakeawaysBiden Struggles Against Trump in High-Stakes 2024 DebateDemocrats Question Replacing Biden: Here’s How It Could WorkSupreme Court Poised to Allow Emergency Abortions in IdahoCheung will become CEO effective Nov. 1,